Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemistry & Biology|November 23, 2006
Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicolNicolas Proisy, Swee Y Sharp, Kathy Boxall, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2010
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2018
Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.
BMC Research Notes|May 25, 2012
Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance SpectroscopyLoreta M Rodrigues, Yuen-Li Chung, Nada M S Al Saffar, et al.
ACS Chemical Biology|September 22, 2011
Targeting the Hsp90 molecular chaperone with novel macrolactams. Synthesis, structural, binding, and cellular studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.
Cancer Research|October 12, 2010
MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signatureNathalie Gaspar, Lynley Marshall, Lara Perryman, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2005
The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitorsKwai-Ming J Cheung, Thomas P Matthews, Karen James, et al.
Journal of Medicinal Chemistry|December 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)Nicola E A Chessum, Swee Y Sharp, John J Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell linesDorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
Pageof 3